Medical Equipment

Drug Eluting Balloons Catheters Market Analysis With Focus On Growth Potential And Future Outlook

April 10, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Drug Eluting Balloons Catheters Market In 2026 And 2030?

The drug eluting balloons catheters market size has recently shown rapid expansion. It is projected to increase from $1.65 billion in 2025 to $1.86 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.5%. The historical growth of this market can be attributed to several factors, including the rising prevalence of coronary artery disease, the increasing adoption of percutaneous coronary interventions, ongoing advancements in balloon catheter materials, the clinical acceptance of paclitaxel-coated devices, and the expansion of interventional cardiology centers.

The drug eluting balloons catheters market is projected to experience rapid growth over the next few years, with its size expected to reach $2.92 billion in 2030, growing at a compound annual growth rate (CAGR) of 11.9%. This expansion during the forecast period can be attributed to factors such as the escalating demand for minimally invasive vascular therapies, the increasing adoption of sirolimus-based balloons, the broadening availability of peripheral vascular disease treatments, a rise in investments dedicated to next-generation catheter technologies, and a heightened focus on ensuring long-term patient outcomes. Significant trends expected in this period include the expanding uptake of drug-coated balloon technologies, their increased utilization in coronary and peripheral interventions, a rising inclination towards stent-free treatment options, the proliferation of advanced drug coating techniques, and an intensified concentration on preventing restenosis.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13429&type=smp

Which Factors Are Influencing The Growth Of The Drug Eluting Balloons Catheters Market?

The expansion of the drug-eluting balloon catheter market is anticipated to be fueled by the increasing occurrence of peripheral and cardiovascular diseases. Cardiovascular diseases (CVDs) encompass various conditions affecting the heart and circulatory system, while peripheral artery disease (PAD) specifically involves narrowed arteries restricting blood flow, predominantly to the limbs. Drug-eluting balloon catheters serve as a treatment for coronary artery disease (CAD), utilizing a semi-compliant angioplasty balloon covered with an anti-proliferative agent, which, upon entering the blood vessel, can prevent restenosis. For example, data from January 2024 by the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted cardiovascular disease mortality rate escalated to 233.3 deaths per 100,000 in 2024, marking a 4.0% year-on-year increase from 224.4 deaths per 100,000 in 2023. Consequently, the increasing incidence of peripheral and cardiovascular diseases is a key factor propelling the drug-eluting balloon catheter market.

Which Segment Categories Are Included In The Drug Eluting Balloons Catheters Market Segment Analysis?

The drug eluting balloons catheters market covered in this report is segmented –

1) By Product: Coronary Artery Disease, Peripheral Vascular Disease, Drug-Eluting Balloon Catheters

2) By Drug: Paclitaxel, Sirolimus, Other Drugs

3) By Raw Material: Nylon, Polyurethane, Other Raw Materials

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Laboratories

Subsegments:

1) By Coronary Artery Disease: Coronary Drug-Eluting Balloon Catheters, Coronary In-Stent Restenosis Drug-Eluting Balloon Catheters, Coronary Small-Vessel Drug-Eluting Balloon Catheters

2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters, Femoro-Popliteal Drug-Eluting Balloon Catheters, Below-the-Knee (BTK) Drug-Eluting Balloon Catheters

3) By Drug-Eluting Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters

Which Trends Are Influencing Demand In The Drug Eluting Balloons Catheters Market?

Leading companies operating within the drug-eluting balloon catheter market are intensifying their focus on developing the latest generation of products featuring advanced technologies to gain a competitive edge. For instance, in March 2024, Boston Scientific Corporation, a US-based biomedical/biotechnology engineering firm and multinational manufacturer of medical devices, announced its receipt of U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB). This AGENT DCB is recognized as the first drug-coated coronary balloon available in the U.S. for treating in-stent restenosis (ISR), a condition where plaque or scar tissue obstructs a stented vessel. The device utilizes a paclitaxel coating to deliver a therapeutic dose to the vessel wall, effectively reducing ISR recurrence without the need for additional stents or radiation. Clinical trials indicated a 49% decrease in heart attack risk at the target site and reported low rates of adverse events.

Who Are The Active Companies Shaping The Drug Eluting Balloons Catheters Market?

Major companies operating in the drug eluting balloons catheters market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

Get The Full Drug Eluting Balloons Catheters Market Report:

https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Which Region Represents The Largest Share Of The Drug Eluting Balloons Catheters Market?

North America was the largest region in the drug eluting balloons catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drug Eluting Balloons Catheters Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=13429&type=smp

Browse Through More Reports Similar to the Global Drug Eluting Balloons Catheters Market 2026, By The Business Research Company

Drug Coated Balloons Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Pta Balloon Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Deflectable Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/deflectable-catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795